Loading data
Company
AbbVie Inc.
ABBVNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 61.16 bn USD | 56.33 bn USD | 54.32 bn USD | 58.05 bn USD | 56.2 bn USD |
| Cost of revenue | 18.2 bn USD | 16.9 bn USD | 20.42 bn USD | 17.41 bn USD | 17.45 bn USD |
| Selling, general and administrative expense | 14.01 bn USD | 14.75 bn USD | 12.87 bn USD | 15.26 bn USD | 12.35 bn USD |
| Operating profit | 15.08 bn USD | 9.14 bn USD | 12.76 bn USD | 18.12 bn USD | 17.92 bn USD |
| Interest expense | 2.89 bn USD | 2.81 bn USD | 2.22 bn USD | 2.23 bn USD | 2.42 bn USD |
| Profit before tax | 6.6 bn USD | 3.72 bn USD | 6.25 bn USD | 13.48 bn USD | 12.99 bn USD |
| Income tax expense | 2.36 bn USD | -570 m USD | 1.38 bn USD | 1.63 bn USD | 1.44 bn USD |
| Net income (reported basis) | 4.23 bn USD | 4.28 bn USD | 4.86 bn USD | 11.84 bn USD | 11.54 bn USD |
| Net income attributable to common shareholders | 4.19 bn USD | 4.24 bn USD | 4.82 bn USD | 11.78 bn USD | 11.47 bn USD |
| Basic earnings per share | 2.37 USD/share | 2.4 USD/share | 2.73 USD/share | 6.65 USD/share | 6.48 USD/share |
| Diluted earnings per share | 2.36 USD/share | 2.39 USD/share | 2.72 USD/share | 6.63 USD/share | 6.45 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.